| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 11015278 | Diabetes Research and Clinical Practice | 2018 | 27 Pages | 
Abstract
												Diabetes-induced nephropathy is associated with ER stress. Gliclazide treatment lessens diabetic nephropathy, probably partially by suppressing the GRP78- and sXBP1-mediated ER response.
											Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Endocrinology
												
											Authors
												Ying-Wen Zhang, Xiuping Wang, Xiaodan Ren, Manling Zhang, 
											